Document Detail

Neuropeptide Y improves myocardial perfusion and function in a swine model of hypercholesterolemia and chronic myocardial ischemia.
MedLine Citation:
PMID:  22982235     Owner:  NLM     Status:  Publisher    
Pharmacologically induced angiogenesis could be a promising option in clinical situations with diffuse inoperable coronary artery disease e.g. metabolic syndrome and diabetes mellitus. The failure of focused cytokine, stem cell and gene therapies to achieve both perfusion and functional improvement in clinical trials suggests a more centralized control mechanism. Neuropeptide-Y (NPY) is one such natural neurotransmitter that is known to exert a multifaceted role during neo-angiogenesis and can possibly act as the central control. To date, the ability to harness the 'master switch' nature of NPY in a specific experimental model of metabolic syndrome and chronic myocardial ischemia has not been conclusively demonstrated. We hypothesized that infiltration of NPY into an area of chronic ischemia in a metabolic syndrome swine model would induce angiogenesis and improve myocardial perfusion and function. An osmotic pump was inserted three weeks after surgical induction of focal myocardial ischemia. We delivered either NPY or placebo for five weeks, after which the myocardial tissue was harvested for analysis. Assessments of myocardial perfusion and function were performed at each stage of the experiment. Local infiltration of NPY significantly improved collateral vessel formation, blood flow and myocardial function. We believe activation of NPY receptors may be a potential target therapy for patients with diffuse coronary artery disease.
Robina Matyal; Louis Chu; Feroze Mahmood; Michael P Robich; Angela Wang; Philip E Hess; Sajid Shahul; Duane S Pinto; Kamal Khabbaz; Frank W Sellke
Related Documents :
17439655 - Ulcerated calcification of the interventricular septum causing transient ischemic attac...
1259565 - Crossed double internal mammary-to-coronary artery grafts.
10336915 - Waiting times and prioritization for coronary artery bypass surgery in new zealand.
12888335 - On-pump coronary artery bypass surgery activates human myocardial nf-kappab and increas...
7800575 - Left heart pacing and cardioembolic stroke.
1810595 - Beneficial effect of beraprost, a prostacyclin-mimetic agent, on post-hypoxic recovery ...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-9-12
Journal Detail:
Title:  Journal of molecular and cellular cardiology     Volume:  -     ISSN:  1095-8584     ISO Abbreviation:  J. Mol. Cell. Cardiol.     Publication Date:  2012 Sep 
Date Detail:
Created Date:  2012-9-18     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0262322     Medline TA:  J Mol Cell Cardiol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2012. Published by Elsevier Ltd.
Beth Israel Deaconess Medical Center, Department of Anesthesia and Critical Care, USA; Harvard Medical School, Boston, MA, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Determination of the critical residues responsible for cardiac myosin binding protein C's interactio...
Next Document:  Targeted imaging of activated caspase-3 in the central nervous system by a dual functional nano-devi...